The US Food and Drug Administration has given approval to Lupin Pharmaceuticals to market its Irbesartan tablets in the country.

The Avapro tablets are used in treating hypertension and nephropathy in type II diabetic patients and accounted for more than $400.7 million in annual sales, according to data from IMS health.
Source-Medindia